W3V-27889-75518 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-02-24
Dose 1 — Pfizer-BioNTech
2021-03-18
Dose 2 — Pfizer-BioNTech
2021-03-21
Registered in v-safe
2021-03-21
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site erythema — Feeling: Poor · Site: Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Diarrhea, Abdominal pain · Be unable to work

Free text: Red spots around injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-21
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-03-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-03-22
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-03-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Nausea, Vomiting · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Adult check-in
2021-03-24
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-25
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-04-03
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-04-07
Call successful
Does not wish to fill out VAERS report
2021-04-08
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-04-15
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-04-22
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-04-29
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-09-18
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-02-24	Pfizer-BioNTech
2	2021-03-18	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-03-21	priority 2/3
2021-03-22	priority 2/3
2021-03-24	Successful 2021-04-07	Does not wish to fill out VAERS report

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-21

Systemic reaction (other): Red spots around injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Injection site erythema	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release